Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology
Integrate Medicine · 31.12.2024
DOI: 10.61958/impy7631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.12.2024. Verfasst von Wei-Jia Gao. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Colon cancer is the third leading cause of cancer-related mortality worldwide. Panax notoginseng saponin, a saponin compound extracted from the root of Panax notoginseng, has demonstrated significant anti-inflammatory and anti-tumor properties. This study aimed to perform a comprehensive bioinformatics analysis to identify the pharmacological targets and effects of notoginseng saponins in colon tissue and colon cancer.
Methods
Data for normal colon tissue, colon cancer, and notoginseng saponins were sourced from GeneCards, Herb, and ETCM databases. Bioinformatics tools, including Jvenn, STRING, and Metascape, were employed to analyze and visualize relationships. Additionally, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-protein interaction (PPI) analyses were conducted on identified intersected targets. Cytoscape were utilized for network visualization.
Results
The Venn diagram highlighted shared biomarkers, offering insights into the molecular pathways affected by notoginseng saponins in colon cancer. PPI network and KEGG pathways analyses identified central hub proteins, including AKT serine/threonine kinase 1 (AKT1), nuclear factor kappa B subunit 1 (NFKB1), and B-cell lymphoma 2 (BCL2), as well as high MCC scoring proteins, such as caspase-3 (CASP3) and mitogen-activated protein kinase 1 (MAPK1), underscoring their pivotal role in cancer biology and regulation by Panax notoginseng saponins.
Conclusions
This study identified potential pharmacological targets of Panax notoginseng saponins in colon cancer. These findings enhance our understanding of the therapeutic mechanisms of Panax notoginseng saponins and their potential clinical applications in treating colon cancer.
Zitieren
APA
Gao, W. (2024). Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology. Integrate Medicine. https://doi.org/10.61958/impy7631
Vancouver
Gao W. Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology. Integrate Medicine. 2024. doi:10.61958/impy7631
BibTeX
@article{Gao2024,
author = {Gao, Wei-Jia},
title = {Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology},
journal = {Integrate Medicine},
year = {2024},
doi = {10.61958/impy7631}
}
EUVIMED